Prospective phase II study of tumor response assessment by CT and FDG-PET/CT following 8 weekly doses of cetuximab in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC).

被引：0
|
作者：
Ley, J. [1 ]
Siegel, B. A. [1 ]
Dehdashti, F. [1 ]
Subramanian, J. [1 ]
Ansstas, G. [1 ]
Rachocki, T. [1 ]
Mathai, J. [1 ]
Wildes, T. M. [1 ]
Kuperman, D. I. [1 ]
Adkins, D. [1 ]
机构：
[1] Washington Univ, Sch Med, St Louis, MO USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.5569
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5569
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Prospective phase II study of tumor response assessment by CT and FDG-PET/CT following 8 weekly doses of cetuximab in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC)
    Ley, J.
    Adkins, D.
    Kuperman, D. I.
    Siegel, B. A.
    Dehdashti, F.
    Wippold, F.
    Trinkaus, K.
    Subramanian, J.
    Rachocki, T.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [2] A prospective trial comparing FDG-PET/CT and CT to assess tumor response to cetuximab in patients with incurable squamous cell carcinoma of the head and neck
    Adkins, Douglas
    Ley, Jessica
    Dehdashti, Farrokh
    Siegel, Marilyn J.
    Wildes, Tanya M.
    Michel, Loren
    Trinkaus, Kathryn
    Siegel, Barry A.
    [J]. CANCER MEDICINE, 2014, 3 (06): : 1493 - 1501
  • [3] Prognostic value of FDG-PET/CT in patients with head and neck squamous cell carcinoma
    Koyasu, S.
    Nakamoto, Y.
    Kikuchi, M.
    Suzuki, K.
    Hayashida, K.
    Togashi, K.
    Itoh, K.
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2012, 39 : S444 - S444
  • [4] FDG-PET/CT of Head and Neck Squamous Cell Carcinoma in a Rat Model
    Aubry, Karine
    Shao, Ziyang
    Monteil, Jacques
    Paraf, Francois
    Besssde, Jean Pierre
    Rigaud, Michel
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2009, 11 (02) : 88 - 93
  • [5] FDG-PET/CT of Head and Neck Squamous Cell Carcinoma in a Rat Model
    Karine Aubry
    Ziyang Shao
    Jacques Monteil
    François Paraf
    Jean Pierre Bessède
    Michel Rigaud
    [J]. Molecular Imaging and Biology, 2009, 11 : 88 - 93
  • [6] Early response monitoring with 18F-FDG PET/CT after Chemoradiotherapy with Cetuximab in head and neck Squamous Cell Carcinoma Patients (HNSCC)
    Barbosa, Felipe
    Stieb, Sonja
    Riesterer, Oliver
    Lang, Stephanie
    Huellner, Martin
    Stolzmann, Paul
    Burger, Irene
    Veit-Haibach, Patrick
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2016, 57
  • [7] Prognostic value of FDG-PET/CT kinetic parameters in patients with head and neck squamous cell carcinomas (HNSCC)
    Abgral, Ronan
    Le Roux, Pierre-Yves
    Rousset, Jean
    Turzo, Alexandre
    Valette, Gerald
    Querellou, Solene
    Keromnes, Nathalie
    Nowak, Emmanuel
    Marianowski, Remi
    Salaun, Pierre
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2012, 53
  • [8] Impact of FDG-PET/CT fused imaging on tumor volume assessment of head-and-neck squamous cell carcinoma
    Tikkakoski, Tapani
    [J]. ACTA RADIOLOGICA, 2008, 49 (06) : 615 - 616
  • [9] Prospective comparison of FDG and FET PET/CT in patients with head and neck squamous cell carcinoma
    Balogova, S.
    Perie, S.
    Kerrou, K.
    Grahek, D.
    Montravers, F.
    Angelard, B.
    Susini, B.
    El Chater, P.
    St Guily, J. Lacau
    Talbot, J. N.
    [J]. MOLECULAR IMAGING AND BIOLOGY, 2008, 10 (06) : 364 - 373
  • [10] Prospective Comparison of FDG and FET PET/CT in Patients with Head and Neck Squamous Cell Carcinoma
    S. Balogova
    S. Périé
    K. Kerrou
    D. Grahek
    F. Montravers
    B. Angelard
    B. Susini
    P. El Chater
    J. Lacau St Guily
    J. N. Talbot
    [J]. Molecular Imaging and Biology, 2008, 10
12345